Finance

Beta
Lists
190A:TYO
Chordia Therapeutics Inc
¥109.00
-2.68%
(-3.00) 1D
May 29, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 190A...
Open
¥112
High
¥112
Low
¥108
Mkt. cap
8.33B
Avg. vol.
1.14M
Volume
742.90K
52-wk high
¥241
52-wk low
¥98
EPS
-¥21
No. of employees
20
Open
¥112
High
¥112
Low
¥108
Mkt. cap
8.33B
Avg. vol.
1.14M
Volume
742.90K
52-wk high
¥241
52-wk low
¥98
EPS
-¥21
No. of employees
20
News stories
From sources across the web
About Chordia Therapeutics Inc
CEO-
Employees20
FoundedOct 12, 2017
Headquarters-
SectorBiotechnology
Websitechordiatherapeutics.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
326.11M
299.45M
229.68M
280.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
98.41M
69.46M
76.58M
75.81M
Operating expense
424.52M
368.90M
306.26M
356.47M
Total operating expenses
424.52M
368.90M
306.26M
356.47M
Operating income
-424.52M
-368.90M
-306.26M
-356.47M
Other non operating income
5.00K
-13.68M
16.43M
18.16M
EBT including unusual items
-422.41M
-385.91M
-294.85M
-337.91M
EBT excluding unusual items
-422.41M
-385.91M
-294.85M
-337.91M
Income tax expense
605.00K
605.00K
475.00K
475.00K
Effective tax rate
-0.14%
-0.16%
-0.16%
-0.14%
Other operating expenses
-
-
-
-
Net income
-423.01M
-386.52M
-295.32M
-338.38M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-423.49M
-368.23M
-305.58M
-355.79M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer